103 related articles for article (PubMed ID: 20412858)
1. Expression of Bv8 in Pichia pastoris to identify structural features for receptor binding.
Miele R; Lattanzi R; Bonaccorsi di Patti MC; Paiardini A; Negri L; Barra D
Protein Expr Purif; 2010 Sep; 73(1):10-4. PubMed ID: 20412858
[TBL] [Abstract][Full Text] [Related]
2. Bv8/Prokineticin proteins and their receptors.
Negri L; Lattanzi R; Giannini E; Melchiorri P
Life Sci; 2007 Sep; 81(14):1103-16. PubMed ID: 17881008
[TBL] [Abstract][Full Text] [Related]
3. Bv8/Prokineticins and their Receptors A New Pronociceptive System.
Negri L; Lattanzi R; Giannini E; Canestrelli M; Nicotra A; Melchiorri P
Int Rev Neurobiol; 2009; 85():145-57. PubMed ID: 19607967
[TBL] [Abstract][Full Text] [Related]
4. Bv8, the amphibian homologue of the mammalian prokineticins, modulates ingestive behaviour in rats.
Negri L; Lattanzi R; Giannini E; De Felice M; Colucci A; Melchiorri P
Br J Pharmacol; 2004 May; 142(1):181-91. PubMed ID: 15066905
[TBL] [Abstract][Full Text] [Related]
5. Biological activities of Bv8 analogues.
Negri L; Lattanzi R; Giannini E; Colucci MA; Mignogna G; Barra D; Grohovaz F; Codazzi F; Kaiser A; Kreil G; Melchiorri P
Br J Pharmacol; 2005 Nov; 146(5):625-32. PubMed ID: 16113687
[TBL] [Abstract][Full Text] [Related]
6. Bv8, the amphibian homologue of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophages.
Martucci C; Franchi S; Giannini E; Tian H; Melchiorri P; Negri L; Sacerdote P
Br J Pharmacol; 2006 Jan; 147(2):225-34. PubMed ID: 16299550
[TBL] [Abstract][Full Text] [Related]
7. Structural determinants required for the bioactivities of prokineticins and identification of prokineticin receptor antagonists.
Bullock CM; Li JD; Zhou QY
Mol Pharmacol; 2004 Mar; 65(3):582-8. PubMed ID: 14978236
[TBL] [Abstract][Full Text] [Related]
8. The Bv8 gene from Bombina orientalis: molecular cloning, genomic organization and functional characterization of the promoter.
Marsango S; di Patti MC; Barra D; Miele R
Peptides; 2009 Dec; 30(12):2182-90. PubMed ID: 19747954
[TBL] [Abstract][Full Text] [Related]
9. Heterologous expression and comparative characterization of the human neuromedin U subtype II receptor using the methylotrophic yeast Pichia pastoris and mammalian cells.
Shukla AK; Haase W; Reinhart C; Michel H
Int J Biochem Cell Biol; 2007; 39(5):931-42. PubMed ID: 17445746
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological activity of a Bv8 analogue modified in position 24.
Lattanzi R; Sacerdote P; Franchi S; Canestrelli M; Miele R; Barra D; Visentin S; DeNuccio C; Porreca F; De Felice M; Guida F; Luongo L; de Novellis V; Maione S; Negri L
Br J Pharmacol; 2012 Jun; 166(3):950-63. PubMed ID: 22122547
[TBL] [Abstract][Full Text] [Related]
11. Chemical synthesis and structure of the prokineticin Bv8.
Morales RA; Daly NL; Vetter I; Mobli M; Napier IA; Craik DJ; Lewis RJ; Christie MJ; King GF; Alewood PF; Durek T
Chembiochem; 2010 Sep; 11(13):1882-8. PubMed ID: 20677202
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two expression platforms in respect to protein yield and quality: Pichia pastoris versus Pichia angusta.
Mack M; Wannemacher M; Hobl B; Pietschmann P; Hock B
Protein Expr Purif; 2009 Aug; 66(2):165-71. PubMed ID: 19358890
[TBL] [Abstract][Full Text] [Related]
13. Bv8/PK2 and prokineticin receptors: a druggable pronociceptive system.
Negri L; Lattanzi R
Curr Opin Pharmacol; 2012 Feb; 12(1):62-6. PubMed ID: 22136937
[TBL] [Abstract][Full Text] [Related]
14. Bv8-prokineticins and their receptors: modulators of pain.
Negri L; Lattanzi R
Curr Pharm Biotechnol; 2011 Oct; 12(10):1720-7. PubMed ID: 21466441
[TBL] [Abstract][Full Text] [Related]
15. Nociceptive sensitization by the secretory protein Bv8.
Negri L; Lattanzi R; Giannini E; Metere A; Colucci M; Barra D; Kreil G; Melchiorri P
Br J Pharmacol; 2002 Dec; 137(8):1147-54. PubMed ID: 12466223
[TBL] [Abstract][Full Text] [Related]
16. Characterization and regulation of bv8 in human blood cells.
Zhong C; Qu X; Tan M; Meng YG; Ferrara N
Clin Cancer Res; 2009 Apr; 15(8):2675-84. PubMed ID: 19336519
[TBL] [Abstract][Full Text] [Related]
17. Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production.
Daly R; Hearn MT
J Mol Recognit; 2005; 18(2):119-38. PubMed ID: 15565717
[TBL] [Abstract][Full Text] [Related]
18. Identification of the N-glycosylation sites on recombinant bovine CD38 expressed in Pichia pastoris: their impact on enzyme stability and catalytic activity.
Muller-Steffner H; Kuhn I; Argentini M; Schuber F
Protein Expr Purif; 2010 Apr; 70(2):151-7. PubMed ID: 19818407
[TBL] [Abstract][Full Text] [Related]
19. [Studies on fermentation conditions and purification of mutant human interleukin-2 expressed in Pichia pastoris].
Liu Y; Su C; Hu YH; Ouyang KQ; Cai SX
Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):430-4. PubMed ID: 16108369
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and mass spectrometric characterization of the human CB2 cannabinoid receptor expressed in Pichia pastoris--importance of correct processing of the N-terminus.
Zhang R; Kim TK; Qiao ZH; Cai J; Pierce WM; Song ZH
Protein Expr Purif; 2007 Oct; 55(2):225-35. PubMed ID: 17500008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
